Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women
- 31 August 1993
- journal article
- clinical trial
- Published by Elsevier in Bone and Mineral
- Vol. 22 (2), 87-94
- https://doi.org/10.1016/s0169-6009(08)80220-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary studyOsteoporosis International, 1991
- Tamoxifen as a Potential Preventive Agent in Healthy Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1990
- Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsBreast Cancer Research and Treatment, 1988
- Tamoxifen Inhibits Osteoclast-Mediated Resorption of Trabecular Bone in Ovarian Hormone-Deficient Rats*Endocrinology, 1988
- Risk of osteoporotic fractures in women with breast cancer: A population-based cohort studyJournal of Chronic Diseases, 1987
- Effects of the Antiestrogens Tamoxifen and Clomiphene on Bone Resorptionin Vitro*Endocrinology, 1986
- Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer PatientsOncology, 1981
- Estimation of hydroxyproline by the AutoAnalyserJournal of Clinical Pathology, 1964